KORU Medical Systems Inc (KRMD) posted 11% revenue growth with gross margin up 500 basis points to 65.2%, while signing new European and African distribution deals and guiding Q4 to high-teens growth.
MAHWAH, N.J., October 20, 2026--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report third quarter 2026 financial results on Tuesday, November 10, 2026. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discus
This is the newest page. Registered accounts read further back.